Skip to Main Content

Author Details

Chang-Qi Zhu
Princess Margaret Cancer Centre, University Health Network
1996
57
33
PMIDPaper TitleJournal TitlePublished Year
35008369Tumor-Associated Regulatory T Cell Expression of LAIR2 Is Prognostic in Lung Adenocarcinoma.Cancers (Basel)2021
31477830Rho guanine nucleotide exchange factor ARHGEF10 is a putative tumor suppressor in pancreatic ductal adenocarcinoma.Oncogene2020
30978569Characterization of Distinct Populations of Carcinoma-Associated Fibroblasts from Non-Small Cell Lung Carcinoma Reveals a Role for ST8SIA2 in Cancer Cell Invasion.Neoplasia2019
31330989Somatic Alteration Burden Involving Non-Cancer Genes Predicts Prognosis in Early-Stage Non-Small Cell Lung Cancer.Cancers (Basel)2019
29507679Differentially expressed microRNAs in lung adenocarcinoma invert effects of copy number aberrations of prognostic genes.Oncotarget2018
30050779Genome-wide copy number analyses of samples from LACE-Bio project identify novel prognostic and predictive markers in early stage non-small cell lung cancer.Transl Lung Cancer Res2018
29699510Putative cancer stem cells may be the key target to inhibit cancer cell repopulation between the intervals of chemoradiation in murine mesothelioma.BMC Cancer2018
27678171Senescent Carcinoma-Associated Fibroblasts Upregulate IL8 to Enhance Prometastatic Phenotypes.Mol Cancer Res2017
28775209Role for High-Affinity IgE Receptor in Prognosis of Lung Adenocarcinoma Patients.Cancer Immunol Res2017
28059079TRIM14 is a Putative Tumor Suppressor and Regulator of Innate Immune Response in Non-Small Cell Lung Cancer.Sci Rep2017
27750381Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.Int J Cancer2017
26148229Integrin α11β1 regulates cancer stromal stiffness and promotes tumorigenicity and metastasis in non-small cell lung cancer.Oncogene2016
27802208MMS19 as a potential predictive marker of adjuvant chemotherapy benefit in resected non-small cell lung cancer.Cancer Biomark2016
25381825Coiled-coil domain containing 68 (CCDC68) demonstrates a tumor-suppressive role in pancreatic ductal adenocarcinoma.Oncogene2015
28843280A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cycle Checkpoints to Drive Resistance of p53-Defective Tumors to Chemotherapy.Cancer Cell2015
26602816A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cycle Checkpoints to Drive Resistance of p53-Defective Tumors to Chemotherapy.Cancer Cell2015
26558161Predicting Prognosis of Early-Stage Non-Small Cell Lung Cancer Using the GeneFx® Lung Signature.PLoS Curr2015
26124487Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung Adenocarcinoma.J Clin Oncol2015
25739673NRF2 Pathway Activation and Adjuvant Chemotherapy Benefit in Lung Squamous Cell Carcinoma.Clin Cancer Res2015
24465899p120RasGAP is a mediator of rho pathway activation and tumorigenicity in the DLD1 colorectal cancer cell line.PLoS One2014
25806294Prognostic markers in lung cancer: is it ready for prime time?Transl Lung Cancer Res2014
25429762Integrated omic analysis of lung cancer reveals metabolism proteome signatures with prognostic impact.Nat Commun2014
24305008Validation of a histology-independent prognostic gene signature for early-stage, non-small-cell lung cancer including stage IA patients.J Thorac Oncol2014
24386371Loss of canonical Smad4 signaling promotes KRAS driven malignant transformation of human pancreatic duct epithelial cells and metastasis.PLoS One2013
22307136L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer.Clin Cancer Res2012
23056397Lipocalin2 promotes invasion, tumorigenicity and gemcitabine resistance in pancreatic ductal adenocarcinoma.PLoS One2012
21474781Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer.Proc Natl Acad Sci U S A2011
21406400Interaction between MYC and MCL1 in the genesis and outcome of non-small-cell lung cancer.Cancer Res2011
20668658Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinoma.PLoS Med2010
20682026A sequence-based approach to identify reference genes for gene expression analysis.BMC Med Genomics2010
20823422Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer.J Clin Oncol2010
20739434Prognostic gene expression signature for squamous cell carcinoma of lung.Clin Cancer Res2010
19801978SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas.Nat Genet2009
20019837Co-overexpression of Met and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells.Neoplasia2009
19808191Understanding prognostic gene expression signatures in lung cancer.Clin Lung Cancer2009
18192688Gab1 but not Grb2 mediates tumor progression in Met overexpressing colorectal cancer cells.Carcinogenesis2008
18641660Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study.Nat Med2008
18632575Genomic markers for malignant progression in pulmonary adenocarcinoma with bronchioloalveolar features.Proc Natl Acad Sci U S A2008
18626007Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21.J Clin Oncol2008
17299390Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma.Br J Cancer2007
18065728Three-gene prognostic classifier for early-stage non small-cell lung cancer.J Clin Oncol2007
18024870Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non small-cell lung cancer.J Clin Oncol2007
17545527KIF14 messenger RNA expression is independently prognostic for outcome in lung cancer.Clin Cancer Res2007
17600088Integrin alpha 11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells.Proc Natl Acad Sci U S A2007
16641908Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer.Br J Cancer2006
17156491Large fragment Bst DNA polymerase for whole genome amplification of DNA from formalin-fixed paraffin-embedded tissues.BMC Genomics2006
16873561Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation.J Clin Pathol2006
16014883Erlotinib in lung cancer - molecular and clinical predictors of outcome.N Engl J Med2005
15041716Skp2 gene copy number aberrations are common in non-small cell lung carcinoma, and its overexpression in tumors with ras mutation is a poor prognostic marker.Clin Cancer Res2004
14761571[A study on lymphocyte DNA damage in traffic policemen in Guangzhou].Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi2003
  • 1 - 50 of 57

Recommended Authors

Zisheng Chen
The Sixth Affiliated Hospital of Guangzhou Medical University
Career Start Year 2018
Number of shared co-authors 0
Zhixin Qiu
UPMC Hillman Cancer Center
Career Start Year 2012
Number of shared co-authors 0
Siddhartha Devarakonda
Siteman Cancer Center, Washington University School of Medicine
Career Start Year 2011
Number of shared co-authors 6
Fei Li
Shanghai Pulmonary Hospital, Tongji University School of Medicine
Career Start Year 2010
Number of shared co-authors 0
Karolina Edlund
Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund
Career Start Year 2008
Number of shared co-authors 0
Yang Xie
Quantitative Biomedical Research Center
Career Start Year 2007
Number of shared co-authors 4
Esther Herpel
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 0
Hye Ryun Kim
Yonsei Cancer Center, Yonsei University College of Medicine
Career Start Year 2005
Number of shared co-authors 2
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 3
Zhuo Chen
The First Hospital of Lanzhou University
Career Start Year 2002
Number of shared co-authors 22
Xin Yang
Peking University Cancer Hospital & Institute
Career Start Year 2002
Number of shared co-authors 1
Yongwei Yu
Changhai Hospital
Career Start Year 2001
Number of shared co-authors 1
David Neil Hayes
Center for Cancer Research, University of Tennessee Health Science Center
Career Start Year 1999
Number of shared co-authors 13
Kostyantyn Krysan
David Geffen School of Medicine at University of California at Los Angeles
Career Start Year 1999
Number of shared co-authors 1
Prudence A Russell
St Vincent's Hospital
Career Start Year 1997
Number of shared co-authors 7
Patrick Micke
Uppsala University
Career Start Year 1997
Number of shared co-authors 0
Ping Yang
Mayo Clinic
Career Start Year 1996
Number of shared co-authors 6
Peter S Hammerman
Novartis Institutes for BioMedical Research
Career Start Year 1996
Number of shared co-authors 8
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 3
Michael Peyton
Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center
Career Start Year 1994
Number of shared co-authors 6
Sichuan Xi
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1994
Number of shared co-authors 0
Holger S??ltmann
German Cancer Research Center (DKFZ)
Career Start Year 1993
Number of shared co-authors 2
Pierre P Massion
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Career Start Year 1993
Number of shared co-authors 3
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 3
David N Watkins
Research Institute in Oncology and Hematology
Career Start Year 1991
Number of shared co-authors 3
Enhua Wang
The First Hospital and College of Basic Medical Sciences, China Medical University
Career Start Year 1990
Number of shared co-authors 1
Charles M Rudin
Memorial Sloan Kettering Cancer Center
Career Start Year 1989
Number of shared co-authors 13
David S Schrump
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 0
David M Jablons
University of California, USA Cardiovascular Research Institute san francisco
Career Start Year 1981
Number of shared co-authors 3
John K Field
University of Liverpool, Molecular & Clinical Cancer Medicine
Career Start Year 1976
Number of shared co-authors 8

Collaborators

Ming-Sound Tsao
University Health Network, University of Toronto
Co-authored papers 47
Frances A Shepherd
University Health Network, Princess Margaret Cancer Centre
Co-authored papers 22
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 14
Igor Jurisica
Schroeder Arthritis Institute
Co-authored papers 14
Roya Navab
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 12
Ni Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 12
Dan Strumpf
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 10
Tai Hing Lam
Co-authored papers 8
Dennis Wang
Sheffield Institute of Translational Neuroscience, University of Sheffield
Co-authored papers 7
Sandy D Der
Toronto General Research Institute, University Health Network
Co-authored papers 7
Christine To
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 6
Ming Li
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 6
Wan L Lam
British Columbia Cancer Research Institute
Co-authored papers 6
Davina Lau
Samuel Lunenfeld Research Institute/Mount Sinai Hospital
Co-authored papers 5
Shingo Sakashita
National Cancer Center Exploratory Oncology Research & Clinical Trial Center
Co-authored papers 5
Bizhan Bandarchi
Princess Margaret Hospital, University of Toronto
Co-authored papers 5
Nhu-An Pham
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 5
Keyue Ding
Queen's University
Co-authored papers 5
Suzanne K Lau
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 4
Geoffrey Liu
The Princess Margaret Cancer Centre/University of Toronto
Co-authored papers 4
Naoki Yanagawa
Yamagata Prefectural Central Hospital
Co-authored papers 4
Josephine Hai
Co-authored papers 4
Vibha Raghavan
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 4
Matthew Meyerson
Broad Institute
Co-authored papers 3
Michael F Moran
Hospital for Sick Children, University of Toronto
Co-authored papers 3
Jiefei Tong
Hospital for Sick Children
Co-authored papers 3
Barbara A Weir
Janssen Research and Development LLC
Co-authored papers 3
Jeremy A Squire
University of Sao Paulo
Co-authored papers 3
Varune R Ramnarine
University of British Columbia
Co-authored papers 2
John D Minna
University of Texas Southwestern Medical Center at Dallas
Co-authored papers 2
Release 1.2